Kohlhaas S - Search Results

1

RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia-an international Delphi consensus.

O'Brien JT, Chouliaras L, Sultana J, Taylor JP, Ballard C; RENEWAL Study Group. O'Brien JT, et al. Alzheimers Res Ther. 2022 Nov 11;14(1):169. doi: 10.1186/s13195-022-01103-7. Alzheimers Res Ther. 2022. PMID: 36369100 Free PMC article. Review.

2

The dementia research career pipeline: Gender disparities in publication authorships and grant funding outcomes at different career stages.

Andreou M, Choi N, Magenti JG, Kohlhaas S, Sancho R. Andreou M, et al. Among authors: kohlhaas s. AMRC Open Res. 2022 Aug 10;4:18. doi: 10.12688/amrcopenres.13072.1. eCollection 2022. AMRC Open Res. 2022. PMID: 38708126 Free PMC article.

3

Poly-Alanine-ε-Caprolacton-Methacrylate as Scaffold Material with Tuneable Biomechanical Properties for Osteochondral Implants.

Hauptmann N, Ludolph J, Rothe H, Rost J, Krupp A, Lechner J, Kohlhaas S, Winkler M, Stender B, Hildebrand G, Liefeith K. Hauptmann N, et al. Among authors: kohlhaas s. Int J Mol Sci. 2022 Mar 14;23(6):3115. doi: 10.3390/ijms23063115. Int J Mol Sci. 2022. PMID: 35328536 Free PMC article.

4

Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposal.

Dangond F, Donnelly A, Hohlfeld R, Lubetzki C, Kohlhaas S, Leocani L, Ciccarelli O, Stankoff B, Sormani MP, Chataway J, Bozzoli F, Cucca F, Melton L, Coetzee T, Salvetti M. Dangond F, et al. Among authors: kohlhaas s. Nat Rev Neurol. 2021 Mar;17(3):185-192. doi: 10.1038/s41582-020-00446-9. Epub 2021 Jan 22. Nat Rev Neurol. 2021. PMID: 33483719 Review.

5

miR-155: an ancient regulator of the immune system.

Vigorito E, Kohlhaas S, Lu D, Leyland R. Vigorito E, et al. Among authors: kohlhaas s. Immunol Rev. 2013 May;253(1):146-57. doi: 10.1111/imr.12057. Immunol Rev. 2013. PMID: 23550644 Review.

6

Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells.

Baou M, Kohlhaas SL, Butterworth M, Vogler M, Dinsdale D, Walewska R, Majid A, Eldering E, Dyer MJ, Cohen GM. Baou M, et al. Among authors: kohlhaas sl. Haematologica. 2010 Sep;95(9):1510-8. doi: 10.3324/haematol.2010.022368. Epub 2010 Apr 7. Haematologica. 2010. PMID: 20378569 Free PMC article.

7

Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells.

Kohlhaas S, Garden OA, Scudamore C, Turner M, Okkenhaug K, Vigorito E. Kohlhaas S, et al. J Immunol. 2009 Mar 1;182(5):2578-82. doi: 10.4049/jimmunol.0803162. J Immunol. 2009. PMID: 19234151

8

microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells.

Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, Das PP, Miska EA, Rodriguez A, Bradley A, Smith KG, Rada C, Enright AJ, Toellner KM, Maclennan IC, Turner M. Vigorito E, et al. Among authors: kohlhaas s. Immunity. 2007 Dec;27(6):847-59. doi: 10.1016/j.immuni.2007.10.009. Epub 2007 Dec 6. Immunity. 2007. PMID: 18055230 Free PMC article.

9

Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.

Kohlhaas SL, Craxton A, Sun XM, Pinkoski MJ, Cohen GM. Kohlhaas SL, et al. J Biol Chem. 2007 Apr 27;282(17):12831-41. doi: 10.1074/jbc.M700438200. Epub 2007 Feb 27. J Biol Chem. 2007. PMID: 17327223 Free article.

10

Inhibition of bortezomib-induced apoptosis by red blood cell uptake.

Wheat LM, Kohlhaas SL, Monbaliu J, De Coster R, Majid A, Walewska RJ, Dyer MJ. Wheat LM, et al. Among authors: kohlhaas sl. Leukemia. 2006 Sep;20(9):1646-9. doi: 10.1038/sj.leu.2404290. Epub 2006 Jun 22. Leukemia. 2006. PMID: 16791268 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page